Power Law company profile

Atara Biotherapeutics

Biotech & Life Sciences · Thousand Oaks, United States · Founded 2012 · IPO 2014 Thoroughbred

Developing t-cell therapies

Valuation

$43M

Market cap · May/2026

Revenue

$121M

Latest reported FY

EBITDA

$39M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

2 investors on Atara Biotherapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Domain Associates

Series B+ 1 investor entered at this stage

Kleiner Perkins

Global footprint

Where Atara Biotherapeutics has talent and traffic

Workforce by country

4 countries with
team presence

🇺🇸 United States99%

🇩🇪 Germany0.8%

🇸🇬 Singapore0.6%

🇨🇴 Colombia0.5%

4 countries shown

Web traffic by country

13K monthly visits
across markets

🇺🇸 United States41.5%

🇮🇳 India24.6%

🇬🇧 United Kingdom16.2%

🇨🇦 Canada13.1%

🇩🇪 Germany2.3%

Top 5 markets shown

Market sentiment

What the market is saying about Atara Biotherapeutics

An AI-synthesized read of the highest-engagement posts about Atara Biotherapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Atara Biotherapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles